C2 C Wealth Management, LLC Exact Sciences Corp Transaction History

C2 C Wealth Management, LLC

  • $108 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 22, 2022
SELL
$35.61 - $76.23 $107,542 - $230,214
-3,020 Closed
0 $0
Q1 2022

Apr 29, 2022
SELL
$57.56 - $82.54 $17,268 - $24,762
-300 Reduced 9.04%
3,020 $204,000
Q4 2021

Feb 23, 2022
BUY
$72.5 - $100.68 $240,700 - $334,257
3,320 New
3,320 $258,000

Others Institutions Holding EXAS

# of Institutions
674
Shares Held
163M
Call Options Held
2.58M
Put Options Held
2.19M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.7B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track C2 C Wealth Management, LLC Portfolio

Follow C2 C Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of C2 C Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on C2 C Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email